Section 4.2: Benign and Malignant Liver Masses

Section 4.2: Benign and Malignant Liver Masses

Introduction to Hepatic Masses

Focal liver masses are common clinical findings that require systematic sonographic evaluation. Distinguishing between benign and malignant liver lesions is a critical competency tested on the ARDMS Abdomen exam. Sonographers must analyze the lesion's echogenicity, margin definition, acoustic enhancement, vascularity, and relationship to surrounding liver tissue, while integrating key clinical risk factors such as oral contraceptive use, chronic hepatitis, cirrhosis, and serum tumor markers like alpha-fetoprotein (AFP).

Benign Liver Masses

Cavernous Hemangioma

Cavernous hemangioma is the most common benign liver tumor. It is composed of large, blood-filled vascular networks lined by endothelial cells. Hemangiomas occur more frequently in women and can enlarge during pregnancy due to hormonal influences.

• Sonographic Appearance: Typically presents as a small (< 3 cm), solitary, well-defined, and homogeneously hyperechoic mass. The hyperechogenicity is caused by multiple acoustic interfaces between the slow-flowing blood and the vascular walls. It often demonstrates posterior acoustic enhancement despite being a solid mass.
• Atypical Patterns: In a fatty liver, a hemangioma may appear hypoechoic relative to the hyperechoic background parenchyma (reverse echogenicity). Large or "giant" hemangiomas (> 5 cm) can exhibit heterogeneous echotexture with central hypoechoic areas due to thrombosis, degeneration, or fibrosis.
• Doppler Characteristics: Because blood flow within the cavernous spaces is extremely slow, color and power Doppler usually demonstrate no internal vascularity, and spectral Doppler is silent. This is a classic exam point: a solid, vascular tumor that shows no color flow.

Focal Nodular Hyperplasia (FNH)

Focal Nodular Hyperplasia is the second most common benign liver mass. It is a hyperplastic response to a congenital vascular malformation rather than a true neoplasm. It contains normal hepatocyte elements, bile ducts, and Kupffer cells, but lacks normal portal triads.

• Sonographic Appearance: Typically isoechoic or mildly hypoechoic to the surrounding liver parenchyma, making it difficult to detect on grayscale alone. Its hallmark feature is a central stellate (star-like) scar, which can appear hypoechoic or hyperechoic depending on the degree of fibrotic tissue.
• Doppler Characteristics: Color Doppler demonstrates a classic "spoke-wheel" vascular pattern, with feeding arteries radiating outward from the central scar. Spectral Doppler shows low-resistance arterial flow with high diastolic velocities.
• Nuclear Medicine Correlation: On a sulfur colloid scan, FNH demonstrates normal or increased uptake ("hot" or "warm" spot) because it contains functioning Kupffer cells that phagocytose the radiopharmaceutical.

Hepatic Adenoma

Hepatic adenomas are benign epithelial liver tumors composed of atypical hepatocytes. They lack bile ducts and Kupffer cells, and possess a network of thin-walled, unsupported vessels that make them highly prone to hemorrhage and rupture.

• Clinical Associations: Strongly associated with the use of oral contraceptives in young women, anabolic steroid use, and Type I glycogen storage disease (von Gierke's disease). If an adenoma ruptures, patients present with acute, severe right upper quadrant pain and hemorrhagic shock.
• Sonographic Appearance: Non-specific and highly variable. Adenomas can be hypoechoic, isoechoic, or hyperechoic. They frequently contain hypoechoic halos or fluid components representing internal hemorrhage or necrosis. Unlike FNH, they do not have a central scar.
• Nuclear Medicine Correlation: Because they lack Kupffer cells, hepatic adenomas appear as "cold" spots on a sulfur colloid scan.

Malignant Liver Masses

Hepatocellular Carcinoma (HCC / Hepatoma)

Hepatocellular carcinoma is the most common primary malignant liver tumor.

• Clinical Associations: Over 80% of HCC cases develop in the setting of pre-existing cirrhosis. Chronic Hepatitis B and C are major risk factors. Laboratory evaluation reveals markedly elevated serum alpha-fetoprotein (AFP) levels.
• Sonographic Appearance: Varies based on the size of the tumor. Small HCCs (< 3 cm) are typically hypoechoic and well-circumscribed. As the mass grows, it becomes larger, heterogeneous, and complex due to internal necrosis, hemorrhage, and calcification. It may display a thin hypoechoic halo.
• Vascular Invasion: HCC has a strong propensity to invade the hepatic vasculature. It can cause portal vein thrombosis (tumor thrombus demonstrating internal vascularity on Doppler, which helps distinguish it from a bland thrombus) and hepatic vein invasion, potentially leading to Budd-Chiari syndrome.

Metastatic Liver Disease

Metastatic disease is the most common malignant liver mass overall, occurring 20 times more frequently than primary liver cancer. The liver is a common site for metastases due to its dual blood supply and portal filtration.

• Sonographic Patterns: The appearance of liver metastases often correlates with the primary site of origin:
  • Target (Bull's Eye) Sign: A hypoechoic halo surrounding a hyperechoic or isoechoic center. This is the most common pattern and is highly suggestive of lung or breast primary malignancies.
  • Hyperechoic Masses: Commonly metastasize from vascular primary tumors, particularly gastrointestinal tract adenocarcinomas (colon cancer) or renal cell carcinoma. Calcifications may be present in mucinous colon cancer metastases.
  • Hyperechoic Masses: Typically originate from lymphoma or breast cancer.
  • Cystic Metastasis: Rare, but can originate from cystadenocarcinoma of the ovary or pancreas.

Hepatoblastoma

Hepatoblastoma is the most common primary malignant liver tumor in infants and children, typically presenting before the age of three. It is associated with Beckwith-Wiedemann syndrome.

• Sonographic Appearance: A large, solitary, heterogeneous, solid mass with poorly defined borders. Foci of calcification casting posterior acoustic shadows are common, along with cystic areas of necrosis.
• Key Labs: Markedly elevated serum AFP levels, which are critical for monitoring treatment response.